(-)-N-(((3R,6S)-6-Methyl-5-oxo-3-thiomorpholinyl)carbonyl)-L-histidyl-L-prolinamide
(3R-cis)-N-((6-Methyl-5-oxo-3-thiomorpholinyl)carbonyl)-L-histidyl-L-prolinamide
CCRIS 7571
CG 3703
CNK 602A

CNK-603
L-Prolinamide, (2R)-2-mercaptopropanoyl-L-cysteinyl-L-histidyl-, cyclic (1-2)-sulfide
Montirelin
Montirelina
Montirelina [Spanish]

Montireline
Montireline [French]
Montirelinum
Montirelinum [Latin]
N-(((3R,6R)-6-Methyl-5-oxo-3-thiomorpholinyl)carbonyl)-L-histidyl-L-prolinamide

NS 3
UNII-30MUJ6YYUY

Systematic Names

L-Prolinamide, (3R,6R)-6-methyl-5-oxo-3-thiomorpholinecarbonyl-L-histidyl-

L-Prolinamide, N-((6-methyl-5-oxo-3-thiomorpholinyl)carbonyl)-L-histidyl-, (3R-cis)-

Montirelin

N-(((3R,6R)-6-Methyl-5-oxo-3-thiomorpholinyl)carbonyl)-L-histidyl-L-prolinamide

Registry Numbers

CAS Registry Number

90243-66-6

FDA UNII

30MUJ6YYUY

System Generated Number

0090243666

Structure Descriptors

InChI

1S/C17H24N6O4S/c1-9-15(25)22-12(7-28-9)16(26)21-11(5-10-6-19-8-20-10)17(27)23-4-2-3-13(23)14(18)24/h6,8-9,11-13H,2-5,7H2,1H3,(H2,18,24)(H,19,20)(H,21,26)(H,22,25)/t9-,11+,12+,13+/m1/s1

InChIKey

RSHMQGIMHQPMEB-IXOXFDKPSA-N

Smiles

C[C@H]1SC[C@H](NC1=O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N3CCC[C@H]3C(=O)N

Toxicity

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD	oral	> 5gm/kg (5000mg/kg)		United States Patent Document. Vol. #4877784,
mouse	LDLo	intravenous	125mg/kg (125mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)	Journal of Toxicological Sciences. Vol. 20(Suppl,

Substance Name: Montirelin [INN]RN: 90243-66-6UNII: 30MUJ6YYUYInChIKey: RSHMQGIMHQPMEB-IXOXFDKPSA-N

Classification Code

Molecular Formula

Molecular Weight

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

Name of Substance

Synonyms